Jérémie Jegu - Concepedia

Author

Jérémie Jegu

Université de Strasbourg ORCID

Also Known As

J Jegu, J Jégu, J, Jégu, J. Jegu, J. Jégu, Jeremie Jegu, Jérémie Jégu, Jérémi Jégu, Jérémie Jegu, Jérémie Jégu

Publications

7.4K

Citations

H-Index

Concepts

All Affiliations

Université de Strasbourg Inserm Hôpitaux Universitaires de Strasbourg Centre Hospitalier Universitaire de Grenoble Cancers et Préventions

About

Jérémie Jegu is an author at Université de Strasbourg specializing in medicine, oncology, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	6.5K
2	Public Health	7	7	6.4K
3	Allergy	2	2	152
4	Allergy Medicine	2	2	152
5	Engineering	1	1	16

Jérémie Jegu

Publications

7.1K

Citations

H-Index

Page 1

	Year	Citations
Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries Claudia Allemani, Tomohiro Matsuda, V Di Carlo, The Lancet EpidemiologyCancer EpidemiologyMedicineGlobal HealthCancer Management	2018	5.9K
Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries Audrey Bonaventure, Rhea Harewood, Charles Stiller, The Lancet Haematology	2017	210
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2) M Matz, Michel P. Coleman, Milena Sant, Gynecologic Oncology International Survival ComparisonsCancer EpidemiologyMedicineEpidemiology Of CancerGynecology	2016	154
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2) M Matz, Michel P. Coleman, Helena Carreira, Gynecologic Oncology Ovarian Cancer SurvivalGynecological SurgeryMedicineWorldwide ComparisonGynecology	2016	131
Asthma among workers in healthcare settings: role of disinfection with quaternary ammonium compounds Jérémie Jegu, M.C. Kopferschmitt, C. Donnay, Clinical & Experimental Allergy AsthmaEnvironmental AllergyOccupational Health SciencesAllergy MedicineAir Quality	2013	117
Trends over three decades of the risk of second primary cancer among patients with head and neck cancer Jérémie Jegu, F. Binder-Foucard, Christian Borel, Oral Oncology Second Primary CancerEpidemiologyNeck CancerCancer EpidemiologyCancer Risk	2012	88
The effect of patient characteristics on second primary cancer risk in France Jérémie Jegu, Marc Colonna, Laëtitia Daubisse‐Marliac, BMC Cancer	2014	83
Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries Naomi Ssenyonga, Charles Stiller, Kayo Nakata, The Lancet Child & Adolescent Health	2022	65
Epidemiology of Merkel cell carcinoma. A population‐based study from 1985 to 2013, in northeastern of France Alice Kieny, B. Cribier, Nicolás Meyer, International Journal of Cancer	2018	47
Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: A population-based study Florent Neumann, Jérémie Jegu, Christiane Mougin, Preventive Medicine EpidemiologyPopulation-based StudyCancer EpidemiologyCancer RiskHuman Papillomavirus Vaccines	2016	42

Page 1